Neat Digest  ·  Archive  ·  Open in app ↗

Roche breast cancer drug giredestrant granted FDA priority review

Score 4.9/10 · Standard · Health · 1 sources · June 2, 2026
Roche breast cancer drug giredestrant granted FDA priority review

Summary: Roche announced that its investigational breast cancer drug giredestrant...

Sources on this story

Reported by 1 sources, including:

  • Seeking Alpha